ARK Investment Management’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-331,001
| Closed | -$1.66M | – | 268 |
|
|
2022
Q2 | $1.66M | Sell |
331,001
-103,342
| -24% | -$518K | 0.01% | 217 |
|
|
2022
Q1 | $2.43M | Buy |
434,343
+85,035
| +24% | +$475K | 0.01% | 202 |
|
|
2021
Q4 | $2.18M | Sell |
349,308
-108,489
| -24% | -$678K | 0.01% | 238 |
|
|
2021
Q3 | $4.52M | Sell |
457,797
-57,010
| -11% | -$563K | 0.01% | 186 |
|
|
2021
Q2 | $4.58M | Buy |
514,807
+38,393
| +8% | +$342K | 0.01% | 248 |
|
|
2021
Q1 | $5.28M | Buy |
+476,414
| New | +$5.28M | 0.01% | 223 |
|
|
2020
Q1 | – | Sell |
-38,536
| Closed | -$323K | – | 210 |
|
|
2019
Q4 | $323K | Buy |
+38,536
| New | +$323K | 0.01% | 183 |
|